M. Wooning
- Urology top 1%
- Urinary Bladder and Prostate Research 7
- Rheumatology top 5%
- Pelvic floor disorders treatments 4
- Osteoarthritis Treatment and Mechanisms 1
- Rheumatoid Arthritis Research and Therapies 1
- Epidemiology top 10%
- Urinary Tract Infections Management 3
-
- Hormonal Regulation and Hypertension 1
-
- HER2/EGFR in Cancer Research 1
-
- Eicosanoids and Hypertension Pharmacology 1
- Co-authors
- J. CambroneroJ.C. AnguloVik KhullarPeter J. BoerrigterPiotr RadziszewskiTomasz RechbergerTed DrogendijkG. Amarenco
- Cited by
- UrologyRheumatologyEpidemiology
- Journals
- British Journal of Urology (1 paper)Osteoarthritis and Cartilage (1 paper)BMC Urology (1 paper)
- Partner nations
- NetherlandsUnited KingdomSpain
In The Last Decade
M. Wooning
8 papers receiving 487 citations
Hit Papers
Peers
Comparison fields: 5 of 51
- Urology 462
- Rheumatology 340
- Epidemiology 258
- Endocrinology, Diabetes and Metabolism 54
- Gastroenterology 15
Countries citing papers authored by M. Wooning
This map shows the geographic impact of M. Wooning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wooning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wooning more than expected).
Fields of papers citing papers by M. Wooning
This network shows the impact of papers produced by M. Wooning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wooning. The network helps show where M. Wooning may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Wooning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2013 | 49 | |
| 3 | Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trialbreakdown → | 2012 | 329 |
| 4 | 2012 | 12 | |
| 5 | The efficacy and tolerability of mirabegron, a potent and selective ß3-adrenoceptor agonist, compared with placebo and tolterodine slow release in patients with overactive bladder – results from a European–Australian Phase III trial | 2011 | 4 |
| 6 | 2011 | 34 | |
| 7 | 2004 | 7 | |
| 8 | 2004 | 54 |
About M. Wooning
M. Wooning is a scholar working on Urology, Rheumatology, Endocrine and Autonomic Systems, Biochemistry and Epidemiology, having authored 8 papers that have together received 499 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (7 papers), Pelvic floor disorders treatments (4 papers), Urinary Tract Infections Management (3 papers), HER2/EGFR in Cancer Research (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper) and Hormonal Regulation and Hypertension (1 paper). The work is most often cited by research in Urology (462 citations), Rheumatology (340 citations), Epidemiology (258 citations), Endocrinology, Diabetes and Metabolism (54 citations) and Gastroenterology (15 citations). M. Wooning has collaborated with scholars based in Netherlands, United Kingdom and Spain. Frequent co-authors include J. Cambronero, J.C. Angulo, Vik Khullar, Peter J. Boerrigter, Piotr Radziszewski, Tomasz Rechberger, Ted Drogendijk, G. Amarenco, Kjetil Høye and Ian Milsom. Their work appears in journals such as British Journal of Urology, Osteoarthritis and Cartilage, BMC Urology, International Urogynecology Journal and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.